Subscribe To
Summit therapeutics: not for retail investors
Summit Therapeutics Inc., backed by biotech billionaire Bob Duggan, has transitioned from developing an...
September 26, 2023, 3:00 pm
Don't miss the boom: 3 biotech stocks set to explode higher
In the dynamic investment realm, one sector that continues to stand out is the area of biotech stocks. ...
September 26, 2023, 1:00 pm
Dyadic and byorna announce a collaboration targeting the production of abundant, low-cost mrna from c1-cells
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS (“bYoRNA”) to...
September 26, 2023, 12:30 pm
Why shares of pliant therapeutics are rising tuesday
Pliant Therapeutics is a clinical-stage biotech. The company said it has enough cash to fund operations through the second half of 2026....
September 26, 2023, 12:10 pm
Verve to present interim data from the heart-1 phase 1b clinical trial of verve-101 in hefh patients at the american heart association’s scientific sessions 2023
Company to hold investor event in conjunction with data presentation on November 12, 2023 BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Verve Therapeuti...
September 26, 2023, 10:30 am
Omega therapeutics: good news met with share markdown
It seems to take a lot to impress those invested in Omega Therapeutics Inc. The shares fell after the biotech reported what on the face of it were p...
September 26, 2023, 9:45 am
Immunovant and roivant jump as new drug shapes up to become blockbuster
There was a bumper boost for stock in two Nasdaq-listed biotechs premarket after an experimental antibody treatment was revealed to have blockbuster p...
September 26, 2023, 9:28 am
These 2 biotech stocks are bucking a down market tuesday
Markets moved lower on Tuesday, giving up some gains from Monday. Immunovant released positive trial data that sent its shares soaring....
September 26, 2023, 9:10 am
Oryzenin market to surpass $676 mn by 2032, says global market insights inc.
Major oryzenin market participants include Axiom Foods, Inc., RiceBran Technologies, Bioway (Xi’an) Organic Ingredients Co., Ltd., Golden Grain Grou...
September 26, 2023, 9:00 am
Tiziana life sciences initiates multi-center phase 2a clinical trial of intranasal foralumab for na-spms
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has commenced site initiation for its lead intranasal foralumab program entering Phase 2a clinical te...
September 26, 2023, 8:16 am
Should you invest in the first trust nyse arca biotechnology etf (fbt)?
Designed to provide broad exposure to the Healthcare - biotech segment of the equity market, the First ...
September 26, 2023, 7:31 am
Acadia pharmaceuticals: difficult market masks progress
Acadia Pharmaceuticals' gains recently disappeared despite the strong launch of Daybue. Poor market conditions are to blame, especially the poor ...
September 26, 2023, 6:44 am
Global cell culture market size to exceed usd 8.75 billion by 2030, at a cagr 8.37% | future of biotechnology
[223 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global Cell Culture Market size & ...
September 26, 2023, 3:56 am
Gain therapeutics to participate at cantor fitzgerald global healthcare conference 2023
BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the disc...
September 25, 2023, 4:05 pm
Omega therapeutics to host conference call to discuss preliminary clinical data for otx-2002 from ongoing mychelangelo™ i trial on september 26
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pio...
September 25, 2023, 4:00 pm
Signal says buy calls on this biotech stock
biotech stock Seagen Inc (NASDAQ:SGEN) scored an all-time high of $215.04 today, building on a Friday...
September 25, 2023, 2:32 pm
Multiple reasons to bet on biotech etf wdna
The healthcare sector is disappointing this year. And the ICE Biotechnology Index is even more of a dud on a year-to-date basis....
September 25, 2023, 1:26 pm
Pds biotech reschedules key opinion leader roundtable addressing current and future treatments for recurrent/metastatic hpv-positive hnscc and the potential application of pds0101
Event to be held on Tuesday, October 3 from 8:00 to 9:00 AM EDT PRINCETON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Na...
September 25, 2023, 12:00 pm
Brainstorm cell shares fall as fda reviewers raise doubts over effectiveness of asl therapy
Shares of BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) fell almost 40% on Monday morning after Food and Drug Administration (FDA) staff reviewers e...
September 25, 2023, 11:28 am
Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy
SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...
September 25, 2023, 9:30 am